Nadine Al-Naamani, MD, MS
Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania
Attending physician, Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Attending physician, Hospital of the University of Pennsylvania
Attending physician, Penn Presbyterian Medical Center
Program Director of the Adult Center for Human Phenomic Science (CHPS) , University of Pennsylvania's Center for Human Phenomic Science (CHPS)
Department: Medicine
Contact information
9021 Gates Building
3600 Spruce Street
Philadelphia, PA 19104
3600 Spruce Street
Philadelphia, PA 19104
Publications
Education:
BS (Chemistry)
American University of Beirut, 1999.
MD (Medicine)
American University of Beirut, 2003.
MS (Clinical and Translational Science)
Sackler School of Graduate Biomedical Sciences at Tufts University, 2016.
Permanent linkBS (Chemistry)
American University of Beirut, 1999.
MD (Medicine)
American University of Beirut, 2003.
MS (Clinical and Translational Science)
Sackler School of Graduate Biomedical Sciences at Tufts University, 2016.
Description of Research Expertise
Pulmonary vascular disease researchSelected Publications
Moutchia J, McClelland RL, Al-Naamani N, Appleby DH, Holmes JH, Minhas J, Mazurek JA, Palevsky HI, Ventetuolo CE, Kawut SM.: Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis. Eur Heart J Feb 2024.Minhas J, Moutchia J, Al-Naamani N, Mazurek JA, Holmes JH, Appleby D, Smith KA, Fritz JS, Pugliese SC, Palevsky HI, Kawut SM.: Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension. Ann Am Thorac Soc Jan 2024.
Anderson MR, Kim JS, Podolanczuk A, Ding J, Al-Naamani N, Allison M, Christie J, Diamond J.: Nonlinear associations between computed tomography-measures of adiposity and long pentraxin-3 in the Multi-Ethnic Study of Atherosclerosis. Obes Sci Pract 10: e708, Nov 2023.
Weatherald J, Moutchia J, Al-Naamani N, McClelland RL, Ventetuolo CE, Palevsky HI, Harhay MO, Kawut SM.: Win Statistics in Pulmonary Arterial Hypertension Clinical Trials. Am J Respir Crit Care Med 208: 1231-1234, Sep 2023.
DuBrock HM, Forde K, Krok K, Patel M, Al-Naamani N, Lin G, Oh JK, Fallon MB, Kawut SM, Krowka MJ.: Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study. Liver Transpl 29: 467-475, May 2023.
Pan HM, McClelland RL, Moutchia J, Appleby DH, Fritz JS, Holmes JH, Minhas J, Palevsky HI, Urbanowicz RJ, Kawut SM, Al-Naamani N.: Heterogeneity of treatment effects by risk in pulmonary arterial hypertension. Eur Respir J 62: 2300190, May 2023.
Blette BS, Moutchia J, Al-Naamani N, Ventetuolo CE, Cheng C, Appleby D, Urbanowicz RJ, Fritz J, Mazurek JA, Li F, Kawut SM, Harhay MO.: Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials. Lancet Respir Med May 2023.
Anderson MR, Diamond J, Shashaty M, Singer JP, Tong Y, Udupa J, Torigian DA, Palmer S, Lederer DJ, Christie JD, Al-Naamani N.: Accuracy and Reproducibility of Automated Measurement of Body Composition: A Lung Transplant Body Composition Cohort Study. Ann Am Thorac Soc Apr 2023.
Keen, JL; Al-Naamani, N; Ventetuolo, CE.: The Future of PAH Treatment. Advances in Pulmonary Hypertension 22(1): 55-61, April 2023.
Cox-Flaherty K, Moutchia J, Krowka MJ, Al-Naamani N, Fallon MB, DuBrock H, Forde KA, Krok K, Doyle MF, Kawut SM, Ventetuolo CE.: Six-Minute walk distance predicts outcomes in liver transplant candidates. Liver Transpl 29: 521-530, Jan 2023.